Publikasi

StockWatch: Novartis Loses More than Market Value After...

Del-desiran was one of three clinical setbacks for Novartis within a week. On Se...

How to Apply for USMLE Step 3 and What’s Required to Re...

If you’re on the journey to becoming a licensed physician in the United States, ...

Bariatric Folding Seat With Legs

Inpro’s Bariatric Folding Seat With Legs is a shower seat designed for use in he...

Bone Marrow-on-a-Chip Model Offers New Window Into Immu...

By reproducing elements of human bone marrow on a chip, scientists have created ...

Transcenta Therapeutics and WuXi Biologics Team Up to A...

Transcenta, headquartered in China and with a pipeline of over ten therapeutic a...

CloudScope Enables Continuous Remote Monitoring of Brai...

Johns Hopkins researchers developed CloudScope, a cloud-based microscope enablin...

STO Building Group Appoints Peter Bulgarelli to Board o...

Construction management firm STO Building Group announced the appointment of Pet...

Pharma Friday – Sept. 11, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and ...

Building trust in Invisalign treatment decisions

Join David Bretton on 16 September at 7pm as he discusses building trust in Invi...

Tooth regrowth drug developer appoints new chief executive

This week’s look across the dental sector includes leadership changes at Toregem...

How Long is COMLEX Level 1 & How Many Questions are On ...

The Comprehensive Osteopathic Medical Licensing Examination (COMLEX) Level 1 is ...

Meet the under-35s shaping the future of biotech

Every year, MIT Technology Review puts together a list of some of the brightest ...

Cancer Treatment Genetic Effects in Healthy Cells May R...

Researchers used DNA sequencing to map mutations in normal tissue from cancer pa...

Samsung Biologics Signs $262 Million Manufacturing Agre...

Alongside decisions involving capacity expansion, officials at Samsung Biologics...

ABEC to expand global manufacturing network with new Wi...

A ribbon-cutting ceremony to mark the opening is scheduled for 24 September, wit...

Exegenesis Bio and Modalis sign research deal for Duche...

The agreement involves the use of Modalis’ CRISPR-GNDM (Guide Nucleotide-Directe...